X0508 4 2026-01-30 0001855175 Contineum Therapeutics, Inc. CTNM 0001861550 Lorrain Daniel S. 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 1 Chief Scientific Officer 0 Stock Option (right to buy) 14.26 2026-01-30 4 A 0 160000 0 A 2036-01-29 Class A Common Stock 160000 160000 D Stock Option (right to buy) 14.26 2026-01-30 4 A 0 6500 0 A 2036-01-29 Class A Common Stock 6500 6500 I By Spouse Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service. Options granted under the Plan in connection with Reporting Person's spouse's continuous service at the Company. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's spouse's continuous service. /s/ Peter Slover, Attorney-in-Fact 2026-01-30